"Noncompliance", a widespread disease - Causes, consequences, treatments;Volkskrankheit "noncompliance" - Ursachen, folgen, therapiemöglichkeiten

PsychoNeuro

Volumn 34, Issue 9, 2008, Pages 405-409

  Seemann, Ute ^a   Kissling, Werner ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adherence; Compliance; Cost of compliance

Indexed keywords

NEUROLEPTIC AGENT;

CHRONIC DISEASE; DEPRESSION; DISEASE COURSE; GERMANY; HEALTH INSURANCE; HOSPITAL COST; HOSPITAL READMISSION; HUMAN; PATIENT COMPLIANCE; PRESCRIPTION; RECURRENCE RISK; SCHIZOPHRENIA; SHORT SURVEY;

EID: 55749091660     PISSN: 16119991     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1099270     Document Type: Short Survey

References (5)

1. Abas M, Vanderpyl J, Le Prou T et al. Psychiatric hospitalization: reasons for admission and alternatives to admission in South Auckland, New Zealand. Aust N Z J Psychiatry 2003; 37: 620-625
2. Dolder CR, Lacro JP, Dunn LB, Jeste DV. Antipsychotic Medication Adherence: Is There a Difference Between Typical and Atypical Agents? Am J Psychiatry 2002; 159: 103-108
3. Gorenoi V, Schönermark MP, Hagen A. Maßnahmen zur Verbesserung der Compliance bzw. Adherence in der Arzneimitteltherapie mit Hinblick auf den Therapieerfolg DAHTA-Datenbank des DIMDI: 1-60 (www.dimdi.de)
4. Kissling W, Vogel C. Erfahrungen mit dem "Münchner Modell" - Integrierte Versorgung - eine Zwischenbilanz. Neurotransmitter 2007; 211-219
5. World Health Organisation. Adherence to long-term therapies: evidence for action. 2003. (www.connected-health.org/programs/medication-adherence.aspx)